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Summary
Background: Atherosclerotic stenoses of the intracranial arteries (ICAS) is associated with high
risk of stroke after TIA. The prevalence of intracranial stenoses is considered to be low in
Caucasians, however population-based data are lacking and only a minority of patients with
acute TIA or stroke is evaluated for ICAS.
Methods: We prospectively examined the prevalence of stenoses of the pre- and intracerebral
vessels using transcranial colour coded sonography (TCCS) in a population based cohort of all
TIA patients in the community of Aarhus, Denmark in the period 1.3.2007—29.2.2008.
Results: The TIA cohort included 203 patients fulﬁlling the diagnostic criteria for TIA. We
examined 195 patients with extra- and intracranial TCCD.
Any stenoses and symptomatic ICAS was found in 12.3% and 8.2%, respectively. The stenoses
were located in the intracranial internal carotid artery in 3.6% and 3.1%, anterior cerebral
artery in 0.5% and 0%, middle cerebral artery in 4.6% and 2.6%, intracranial vertebral artery in
2.1% and 1.5%, and in the basilar artery in 1.5% and 1.5%, respectively. In comparison, we found
any stenoses and symptomatic stenoses in the extracranial carotid artery in 14.4% and 10.8%,
and the extracranial vertebral artery in 5.6% and 2.1% of the patients, respectively. Carotid
occlusion was found in 3.6%, combined extra- and intracranial stenoses in 4.9%.
Conclusion: The prevalence of ICAS was in this population-based TIA cohort of Caucasians com-
parable with the prevalence of carotid stenoses. Systematic evaluation for intracranial stenoses
should be considered in all patients with acute ischemic cerebrovascular disease.
 acces© 2012 Elsevier GmbH.Open∗ Corresponding author at: Department of Neurology, Aarhus Uni-
versity Hospital, Aarhus Hospital, Nørrebrogade 44, 8000 Aarhus C,
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tenoses in the intracranial vessels (ICAS), caused by
s under CC BY-NC-ND license.therosclerosis, are associated with a risk of stroke after TIA
f 11—23% during the ﬁrst year [1—3]. The prevalence of ICAS
as been reported to be high in east Asian countries includ-
ng Japan and China, but is supposed to be low in Caucasians
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Results
We identiﬁed 203 patients fulﬁlling the diagnostic criteria
for TIA. The characteristics of the patients are shown in
Table 1 Patient characteristics.
TIA
N = 203
Age 66.3 (range 19—93)
Male 109 (53.7%)
Smoking (active) 30.5%
High alcohol consumption 8.9%
Hypertension 71.9%
Diabetes 15.3%
Hypercholesterolaemia
(>5mmol/l)
82%
Atrial ﬁbrillation 8.9%
All cardioembolic causesa 15.8%
PADb (history or symptoms) 5.9%
PAD, incl. ABIc measurement 19.2%
d08
4—6]. However, population-based data on the prevalence of
CAS in Caucasian TIA-patients are not available.
In this study, we examined the prevalence of ICAS in a
opulation based purely Caucasian cohort of TIA-patients
y using TCCS.1
aterial and methods
tudy setting and design
e conducted this cohort study within the population served
y the Department of Neurology, Aarhus University Hospital.
he department serves as the only local stroke unit in the
arhus area, which is clearly deﬁned and mostly urban. The
atchment area had 328,542 inhabitants in 2007. The Dan-
sh National Health Service provides tax-supported health
are for all inhabitants, guaranteeing free access to gen-
ral practitioners and hospitals. All acute medical conditions
ncluding TIA are exclusively treated at public hospitals,
ither as in or as outpatients.
dentiﬁcation of TIA patients
e established an acute TIA-team, which served TIA-
atients both on the stroke unit and the TIA-clinic. Patients
ith TIA symptoms during the preceding 48 h or crescendo
IA were admitted directly to the stroke unit and monitored
or 1—2 days. All other patients were seen as outpatients
—3 days after received referral.
TIA was deﬁned as a sudden focal neurologic deﬁcit of
resumed vascular origin lasting less than 24 h.
Inclusion criteria were: TIA according to deﬁnition, resi-
ence in the Aarhus area, TIA during the last six months, and
ate of referral 1 March 2007—28 February 2008. Patients
ith a modiﬁed Rankin Score (mRS) >2 were excluded.
nformed consent was obtained from all participants. All
atients fulﬁlling the inclusion criteria for TIA were regis-
ered prospectively, including those admitted for suspected
troke but ending up as TIA.
atient characteristics
he TIA diagnosis was made by a specialist. Patients under-
ent a neurological examination (more than 95% of the TIA
atients were examined by the ﬁrst author), CT or MR of the
rain, ECG, laboratory tests and ankle brachial index. Fur-
hermore, we performed duplex sonography of the extra-
nd intracranial vessels (TCCS). All ultrasound examinations
ere done by one experienced neurologist, performing at
east 500 examinations per year and certiﬁed by the Euro-
ean Society of Neurosonoly and Cerebral Haemodynamics
ESNCH). Atherosclerosis of the carotid arteries was con-
idered signiﬁcant if a stenoses ≥50% was found (NASCET
riteria). Intracranial stenoses were deﬁned according to
1 Abbreviations: ICAS: stenosis in the intracranial vessels transcra-
ial; TCCS: colour coded sonography; ACA: anterior cerebral artery;
CA: middle cerebral artery; PCA: posterior cerebral artery; VA:
ertebral artery; BA: basilar artery; ICA: internal carotid artery.P. von Weitzel-Mudersbach et al.
he criteria established by Baumgartner: stenoses in the
nterior (ACA), middle (MCA) and posterior (PCA) cerebral
rtery was deﬁned by peak systolic velocity of ≥120 cm/s,
155 cm/s, and ≥100 cm/s respectively, Stenoses in the VA
nd BA was deﬁned by peak systolic velocity of ≥90 cm/s,
nd ≥100 cm/s respectively [7]. Additionally to these cri-
eria, stenoses in ICA, and the extracranial VA was deﬁned
y systolic peak velocity ≥120 cm/s. All intracranial veloc-
ties were measured with an insonation angle of 0◦ without
ngle correction. A stenosis was considered symptomatic if a
atient had TIA symptoms during the last six months before
nclusion, related to the supply area of a carotid artery
ith a signiﬁcant stenosis, or an extracranial vertebral or
n intracranial stenosis according to the criteria above.
atients with combined extra- and intracranial stenoses e.g.
CA and MCA-stenoses on the symptomatic side were counted
oth as symptomatic ICA- and MCA-stenoses.
Hypertension was deﬁned as history of hypertension
r antihypertensive treatment, blood pressure systolic
140mm Hg, or diastolic >90mm Hg. Hypercholesterolemia
as deﬁned as total cholesterol >5.0mmol/l, LDL choles-
erol >3.0mmol/l, or cholesterol lowering treatment.
iabetes was deﬁned as history or treatment for diabetes,
asting glucose >6.9mmol/l, or any glucose >10.9mmol/l.
eripheral artery disease was deﬁned as history of claudica-
ion, or ankle-brachial index <0.9.
Our study was approved by the local ethics committee
protocol number 20060188).History of MI 7.4%
History of ischaemic heart disease
including MI
12.3%
History of stroke 11.8%
History of TIA 10.4%
a Atrial ﬁbrillation, dilated cardiomyopathy, mitral valve pro-
lapse, patent oval foramen.
b PAD: peripheral arterial disease.
c ABI: Ankel brachial index.
d MI: myocardial infarction.
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Table 2 Frequencies of precerebral and intracranial stenoses in 195 TIA patients.
All stenoses/occlusions
(%)
Symptomatic
stenoses (%)
Symptomatic
occlusions (%)
All extra- and intracranial stenoses (N = 195) 27.2% (n = 53) 19.5% (n = 38) 3.1% (n = 6)
Extracranial common/internal carotid artery 16.4 (32) 10.8 (21) 3.1 (6)
Extracranial vertebral artery 5.6 a(11) 2.1 a(4)
Intracranial carotid artery 3.6 (7) 3.1 (6)
Anterior cerebral artery 0.5 (1) 0 (0)
Middle cerebral artery 4.6 (9) 2.6 (5)
Posterior cerebral artery 1.5 (3) 0 (0)
Intracranial vertebral artery 2.1 (4) 1.5 (3)
Basilar artery 1.5 (3) 1.5 (3)
All intracranial stenoses 12.3 (24) 8.2 (16)
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RCombined extra- and intracranial stenoses 4.9 (10
a Including one patient with vertebral artery dissection.
Table 1. In 195 patients we conducted TCCS of the pre-
or intracranial vessels. In 39 patients the transcranial part
of the examination was partly inconclusive due to insufﬁ-
cient bone window. Ultrasound contrast agents were not
used in this study. Any stenoses or occlusion and symp-
tomatic stenoses or occlusion was found in 27.2% and 22.6%,
respectively. We found extracranial carotid artery stenoses
in 14.4% and 10.4%, carotid occlusion in 4.1% and 3.1%,
extracranial vertebral artery stenoses in 5.6% and 2.1%
(including one dissection), and intracranial artery stenoses
in 12.3% and 8.2%, respectively (Table 2).
Discussion
In our population-based TIA study, the prevalence of symp-
tomatic ICAS diagnosed according to TCCS criteria was only
slightly lower than the prevalence of symptomatic carotid
stenosis. Furthermore, the estimated prevalence of ICAS
may even be conservative due to the incomplete intracranial
vascular assessment in 20% of the patients.
To the best of our knowledge, no other population-
based data on the prevalence of ICAS are available. In
the French SOS-TIA study, 1.823 unselected consecutive
patients admitted at an acute TIA-clinic were examined
with transcranial Doppler, and a prevalence of 8.8% for
any ICAS or intracranial occlusion was found. Restricting
the analysis in that study to patients deﬁned as with def-
inite TIA or minor stroke, the prevalence of ICAS increased
to 11.5%, and about half of them were symptomatic
[7].
In Denmark only a minority of patients with acute TIA or
stroke is currently evaluated for ICAS. This may be explained
by the assumption that intracranial atherosclerotic disease
in Caucasians is rare, and by the lack of evidence for a
speciﬁc treatment. Recently published data provides some
evidence for the efﬁcacy of dual platelet inhibition [8], and
preliminary data on rapid and aggressive treatment seem to
show a reduction of the risk of stroke in patients with TIA
and intracranial stenoses [9]. Moreover, intra-arterial stent-
ing may be an option in unstable ICAS not responding to
medical treatment, even if this cannot be recommended as
standard procedure [10].onclusion
he prevalence of ICAS in TIA-patients was substantial in
population-based cohort of Caucasians. The prevalence
f symptomatic stenoses or occlusion was almost similar
n the precerebral and intracerebral arteries, including a
inor number of tandem stenoses in the pre- and intracere-
ral vessels. We suggest that a systematic screening with
ltrasound examination for intracranial stenoses should be
onsidered in all patients with acute ischaemic cerebrovas-
ular disease.
ources of funding
his study was supported by the Danish Heart Foundation
nd the Research Council in the former Aarhus County. None
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